| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/31/2006 | CA2598518A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | CA2598418A1 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | CA2598330A1 1-(2h)-isoquinolone derivative |
| 08/31/2006 | CA2598133A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 08/30/2006 | EP1695964A1 Quinoline derivatives for use as intermediates in the synthesis of heterocyclylalcoyl piperidines |
| 08/30/2006 | EP1695962A1 Cyclic amine derivative having heteroaryl ring |
| 08/30/2006 | EP1695961A1 Urea derivative, process for producing the same, and use |
| 08/30/2006 | EP1695960A1 Near-infrared fluorescent contrast medium |
| 08/30/2006 | EP1695705A1 Compounds effecting glucokinase |
| 08/30/2006 | EP1694775A1 Reagent for detecting an analyte |
| 08/30/2006 | EP1694686A1 Kinase inhibitors |
| 08/30/2006 | EP1694672A1 Novel chelating agents and highly luminescent and stable chelates and their use |
| 08/30/2006 | EP1694671A2 Quinoxalines useful as inhibitors of protein kinases |
| 08/30/2006 | EP1694670A1 Pyrazine derivatives as effective compounds against infectious diseases |
| 08/30/2006 | EP1694668A1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics |
| 08/30/2006 | EP1694667A2 Polymorphs of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3, 3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid hydrochloride and mesalyte salts |
| 08/30/2006 | EP1694653A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/30/2006 | EP1694651A1 Herbicidal pyrimidines |
| 08/30/2006 | EP1694649A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 08/30/2006 | EP1694644A2 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b |
| 08/30/2006 | EP1694643A1 Carboxamide derivatives |
| 08/30/2006 | EP1694640A1 Anti-cancer agents |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694329A2 Diamine and iminodiacetic acid hydroxamic acid derivates |
| 08/30/2006 | EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/30/2006 | EP1562596B1 Derivatives of pyridinalkyl-amonoalkyl-1h-indole inhibiting receptors 5-ht and recapture of serotonin which can be used as antidepressant and anxiolitic |
| 08/30/2006 | EP1562540B1 N-aryl-4,5-diaminopyrazols and dyes containing said compounds |
| 08/30/2006 | EP1505966A4 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 08/30/2006 | EP1490056B1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 08/30/2006 | EP1458682B1 1,4-dihydro-1,4-diphenylpyridine derivatives |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1373250B1 Viologen linked acridine based molecule and process for the preparation thereof |
| 08/30/2006 | EP1345924B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 08/30/2006 | EP1335722B1 Indolyl-sulfonyl- compounds useful in the treatment of cns disorders |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | EP1317429B1 Amidine inhibitors of serine proteases |
| 08/30/2006 | CN1826339A 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 08/30/2006 | CN1826335A Process for producing 1,2,4-triazole compound and intermediate therefor |
| 08/30/2006 | CN1826334A Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/30/2006 | CN1826332A Method for preparing 3-halo-4,5-dihydro-1H-pyrazoles |
| 08/30/2006 | CN1826328A Substituted pyridin-2-ylamine analogues |
| 08/30/2006 | CN1826325A 4,5-dihydro-imidazole as P2X7 ion channel blockers |
| 08/30/2006 | CN1826324A Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| 08/30/2006 | CN1826323A 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 08/30/2006 | CN1826321A Quinolone derivative or its salt |
| 08/30/2006 | CN1826317A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 08/30/2006 | CN1826119A Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 08/30/2006 | CN1826116A Piperidine derivatives as melanocortin-4 receptor agonists |
| 08/30/2006 | CN1826115A Substituted piperidine compounds and methods of their use |
| 08/30/2006 | CN1826111A Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
| 08/30/2006 | CN1824662A Substituted pyridine herbicides |
| 08/30/2006 | CN1272333C 2-pyridyl-1H-benzimidazole-4-amide derivatives |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272326C Phenylpyridazine derivatives and drugs containing the same |
| 08/30/2006 | CN1272316C Benzamides and related inhibitors of factor Xa |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/29/2006 | US7098340 Quinoline/chromene derivatives as androgen antagonist |
| 08/29/2006 | US7098331 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098234 Indole derivatives, process for preparation of the same and use thereof |
| 08/29/2006 | US7098231 Viral polymerase inhibitors |
| 08/29/2006 | US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 08/29/2006 | US7098224 Treating psoriasis, gastroesophageal reflux, Zollinger-Ellison Syndrome; antiulcer and antisecretory agents |
| 08/29/2006 | US7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 08/29/2006 | US7098222 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 08/29/2006 | US7098219 Inhibitors of cellular efflux pumps of microbes |
| 08/29/2006 | US7098215 Nitrogenous compounds and antiviral drugs containing the same |
| 08/29/2006 | US7098214 Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders |
| 08/29/2006 | US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098211 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 08/29/2006 | US7097706 non-calcined clay composite includes clay, lime, blast furnace slag, alkaline chemical, and water in specified amounts, and has high compression strength due to an ionic coagulation reaction, a pozzolan reaction, and a latent hydraulic reaction |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2213996C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006089311A1 Vanilloid receptor ligands and their use in treatments |
| 08/24/2006 | WO2006088954A1 Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 08/24/2006 | WO2006088949A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
| 08/24/2006 | WO2006088921A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088920A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088919A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088840A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088837A2 Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088836A2 Piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088813A1 Substituted pyrazoles as modulators of chemokine receptors |
| 08/24/2006 | WO2006088075A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative |
| 08/24/2006 | WO2006087543A1 Antibacterial piperidine derivatives |
| 08/24/2006 | WO2006087538A1 Chemical compounds |
| 08/24/2006 | WO2006087355A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | WO2006087309A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters |
| 08/24/2006 | WO2006087308A1 METHYLPHENYLCARBAMIC ACID 5-(4-ISOBUTYL-2,6,-DIOXOPIPERAZIN-l-YL) PYRIDINYL-2-YL ESTER ANS SALTS AS HORMONE SENSITIVE LIPASE INHIBITORS |
| 08/24/2006 | WO2006065686A3 Spiro derivatives as lipoxygenase inhibitors |
| 08/24/2006 | WO2006035067A3 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 08/24/2006 | WO2006014877A3 Potassium channel inhibitors |
| 08/24/2006 | WO2006001958A3 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 08/24/2006 | WO2005090333A8 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 08/24/2006 | WO2005004810A3 Arylsulfonamide derivatives |